We are live on
!
Find out more
ECM
Elgethun Capital Management Portfolio holdings
AUM
$718M
1-Year Est. Return
18.6%
This Fund
S&P 500
This Quarter
Est. Return
+6.72%
1 Year Est. Return
+18.6%
3 Year Est. Return
+61.47%
5 Year Est. Return
+71.42%
10 Year Est. Return
–
AUM
$332M
AUM Growth
+$15.8M
(+5%)
Cap. Flow
-$2.51M
Cap. Flow
% of AUM
-0.76%
Top 10 Holdings %
Top 10 Hldgs %
44.22%
Holding
160
New
29
Increased
68
Reduced
28
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.93M |
| 2 |
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
|
+$741K |
| 3 |
Pathward Financial
CASH
|
+$562K |
| 4 |
General Motors
GM
|
+$201K |
| 5 |
Mondelez International
MDLZ
|
+$193K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$3.27M |
| 2 |
Bank of America
BAC
|
+$2.93M |
| 3 |
JPMorgan Chase
JPM
|
+$2.54M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$842K |
| 5 |
Green Brick Partners
GRBK
|
+$233K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.94% |
| 2 | Consumer Discretionary | 9.9% |
| 3 | Communication Services | 8.05% |
| 4 | Technology | 5.54% |
| 5 | Healthcare | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Lineage Cell Therapeutics
LCTX
$278M
| $21.1K | 0.01% |
15,000
| – | – |
|
|
BHIL
152
DELISTED
Benson Hill, Inc.
BHIL
| $20.8K | 0.01% |
457
| – | – |
|
153
Sky Harbour Group Warrants
SKYH.WS
$21.4M
| $15.9K | ﹤0.01% |
51,380
-15,400
| -23% | -$5.71K |
|
|
NGD
154
DELISTED
New Gold Inc
NGD
| $13.2K | ﹤0.01% |
12,000
| – | – |
|
155
SAB Biotherapeutics
SABS
$355M
| $8.25K | ﹤0.01% |
994
+290
| +41% | +$2.38K |
|
|
OPFI.WS
156
DELISTED
OppFi Inc Warrants
OPFI.WS
| $1.87K | ﹤0.01% |
+26,766
| New | +$1.93K |
|
|
BNY
157
Bank of New York Mellon
BNY
$107B
| – | – |
-71,940
| Closed | -$3.27M |
|
|
BOXD
158
DELISTED
Boxed, Inc.
BOXD
| – | – |
-9,900
| Closed | -$1.88K |
|
Similar funds
TFA
KC
EI
CFO
AIM
BFO
ECM
GEA
Elgethun Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Elgethun Capital Management held 160 positions worth $332M, up 5% from $316M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Elgethun Capital Management's Q2 2023 filing shows 29 new, 68 increased, 28 reduced and 2 closed positions. Its largest new stake was General Motors: 5,821 shares worth $224K. The largest sale was Bank of New York Mellon, an estimated $3.27M.
By sector, the portfolio is most concentrated in Financials at 34% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Elgethun Capital Management's largest Q2 2023 buy was General Motors: 5,821 shares worth $224K.
- Elgethun Capital Management added most to Charles Schwab in Q2 2023, an estimated $1.93M increase.
- Elgethun Capital Management's biggest Q2 2023 reduction was Bank of America, cutting an estimated $2.93M.
- Elgethun Capital Management fully exited Bank of New York Mellon in Q2 2023, selling an estimated $3.27M.
- Elgethun Capital Management's ten largest holdings make up 44% of its $332M portfolio in Q2 2023.
- Elgethun Capital Management opened 29 new positions and closed 2 in Q2 2023.
- Elgethun Capital Management's portfolio value rose 5% quarter-over-quarter to $332M.
Based on Elgethun Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.